By Dorothy Atkins ( February 27, 2023, 7:37 PM EST) -- Intercept Pharmaceuticals, MSN Pharmaceuticals and Apotex told a Delaware federal judge that they've cut deals to end Intercept's claims that Apotex's proposed generic version of Ocaliva, treatment for a rare liver disease, infringes its patents, resolving the consolidated litigation just as the parties were to face off in a bench trial on Monday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.